Abstract-In this work the design of a Luenberger observer is proposed to estimate the unmeasurable state space variables from Hovorka's model. This model is linearized and evaluated in an operation point where Luenberger observer is designed using the Ackermann methodology. The observer is employed to estimate the unmeasurable variables of virtual patients which are generated by Bergman's model. Once the unmeasurable state variables are obtained by the Luenberger observer using only the input-output information of the Bergman's model, a control algorithm based on eigenvalues relocation trough Ackermann methodology for linear systems is applied. In this methodology, a constant feedback gain vector is obtained in order to compute the control signal (insulin) to be applied to virtual patient and keep on normoglycemia rank. The carbohydrates ingestion is considered as the main disturbances. In order to assess the proposed methodology, two tests are designed: the first one consists of changing the reference signal in order to evaluate the control sensitivity; and the second one includes different proportions of prandial insulin used in open-loop to try the controller response under distinct operation conditions. The results are obtained via simulation using Simulink of Matlab.
Introduction
Type 1 diabetes Mellitus (T1DM) is a chronic disease, which occurs when the pancreas does not produce insulin, because beta-cells are destroyed. Hyperglycemia is a common effect of uncontrolled T1DM and over time leads to serious damage to many of the body's systems. Currently, 347 million people worldwide have diabetes, more than 80% of diabetes deaths occur in low and middle income countries. World Health Organization estimates that deaths caused by diabetes will double between 2005 and 2030 and will be the 7th leading cause of death in 2030.
At present, it is impossible to regenerate the beta cells and cure this disease. T1DM can be controlled by exogenous insulin supplying subcutaneous injections and by the glucose measurements using glucometers or continuous glucose subcutaneous sensors monitoring (CGM) [1] . This treatment is very invasive and painful. A serious complication of the therapies is the hypoglycemia which appears when the glucose level is lower than 70 mg/dl. CGM has been improved in the last years, the measurements are more accurate and are made in real-time, with shorter sample periods. But they continued to have problems as duration, calibrations and delays [2] .
Continuous subcutaneous insulin infusion systems (CSII) uses an insulin pump and reduces the therapy injections painful. CSII can be used to optimize the patient's insulin therapy and to improve lifestyle flexibility. The use of CSII together CGM is known as sensor-augmented pump (SAP) therapy [2] .
The artificial pancreas (AP) should automatically keep the blood glucose levels to close normal levels, avoiding hypoglycaemia without human interaction. An AP is composed by a control algorithm that determines the amount of insulin needed and infusioned, a pump and CGM as primary source. Some of the closed-loop (CL) techniques applied in diabetes to design the control algorithm include PID (proportional-integral-derivative) approximations, model predictive control, fuzzy control, and robust control. Hybrid closed-loop (HCL) control has been also evaluated as a means to reduce the peak postprandial glucose levels [3] .
The majority of control algorithms need a model of the plant (system to control, in T1DM the patient) to be designed, fitted or implemented. The availability of a glucose model to simulate the behavior in particular of T1DM patients gives the possibility of design and evaluate insulin infusion algorithms.
In T1DM the most common models are based in compartments. A glucose compartmental model is a set of nonlinear equations that represents the glucose and insulin masses or concentrations. The set of equations emulates the glucoregulatory system trying to describe the dynamics of blood glucose or subcutaneous glucose through the insulin and meals.
Sometimes the real experiments cannot be done at all, because they are dangerous in vivo, difficult or not ethical. There are several compartmental models to evaluate the glucose on people with T1DM. In the last ten years, two have been the compartmentals models widely used: 1) Bergman's model (BM) also known as minimal model, which consider only the glucose and insulin compartments and the interaction between them [4] ; and 2) Hovorka's model (HM) in which the insulin has 3 different sensibilities on glucose distribution/transport, disposal, and endogenous production [5] , [6] . Cobelli's model in which patient has daily events and T1DM patients have a lot of problems to fit the insulin therapy to their life habits. The main problem is not to use too much insulin in order to avoid hypoglycemia events. The goal of all alternative treatments in T1DM is to keep the glucose concentration in normal ranges using as much doses of exogenous insulin as necessary. CGM and CSII require the subcutaneous route, which complicates control because of delays in both routes, measurement and insulin action.
In control design, it is difficult to infer the behavior of the nonlinear systems, which have internal or external disturbances, unknown parameters or unmodeled dynamics and delays. When a control law it is designed using a mathematical model, is necessary to estimate the unmeasurable variables. A useful tool to estimate the unmeasurable variables are the observers; there exists a wide variety of them applied in very different fields successfully as Kalman filter, observers with sliding modes, nonlinear observers and Luenberger observer [8] [9] .
In this work we propose to design a Luenberger observer in order to estimate the unmeasurable state space variables (as it is done in [10] ). The HM is linearized and an operation point is selected to evaluate the model; this linearized model is used to design the Luenberger observer. The observer based on the HM is employed to estimate the unmeasurable variables of virtual patients (VP) generated by BM. Once the unmeasurable state variables are obtained by the Luenberger observer using only the input-output information (insulinglucose) of the BM, a control algorithm based on eigenvalues relocation trough Ackermann methodology for linear systems is applied. In this methodology, a constant feedback gain vector is obtained in order to compute the control signal (insulin) to be applied to VP and keep on normoglycemic rank. The main external disturbances included in this work is the carbohydrates (CHOs) ingestion. Two tests are designed to evaluated the performance of the control algorithm: 1) Target sensibility, it consists of changing the reference signal in order to evaluate the steady state control; and 2) Prandial sensibility, it includes different proportions of prandial insulin used in open-loop (OL) or CSII to try the controller response under distinct operation conditions.
II. Hovorka´s model
HM is one of the most accepted models describing the glucose-insulin dynamic. Roman Hovorka modelled the diabetes disease with eight compartmental differential equations in 2004 [6] and in subsequent works updated his model including the equation of CGM sensor [11] . HM is represented in states space as: The renal glucose clearance (f R ) appears when the glucose is above threshold of 9 mmol/l, which can be represented as:
The total non-insulin-dependent glucose flux (f 01 c ) corrected depends on glucose concentration, it is represented as:
In this work, the HM (1) is linearized around of an operation point in order to design the Luenberger observer. This observer is used to design a control law by eigenvalues relocation. This procedure is explained in section III. The HM (1) and its parameters are obtained from [5] [6] and are used to parameterize the observer during simulations.
III. Proposed methodology
In this section, we proposed the procedure for designing the Luenberger observer in the T1DM HM and applying it in BM to CL.
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A. Luenberger observer
The assumption that all state variables are available for feedback may not hold in practice, because in the case of T1DM nowadays it is not feasible to measure all HM variables for an ambulatory AP. In this paper, HM (1) can be represented in a general form as:
where f(x) and g(x) are nonlinear functions; d(t) represents the external disturbances (described in equation (2)) and h(x) is the output function.
In [10] , the Luenberger observer linear theory is extended for general nonlinear system  with following structure:
 where the Luenberger gain vector l is calculated by eigenvalues relocation trough Ackermann methodology, x is the estimated states vector for x. In order to select the desired eigenvalues, the system  is linearized using the Jacobian to obtain: , , ,
where A is the state matrix and b is the input vector and c is the output vector. The operation point ρ is selected when y=90 mg/dl. That is, the T1DM patient is into normoglycemia band. Then, the linearized system is: . The observer (6) will estimate the unmeasurable state variables of HM (1) with the form (5). Even when output of system (1) is considered available for measuring, in this work the output estimation of y=C=x 1 in system (1) will contribute to estimate the state variable G in BM.
B. Control algorithm
With all the state space variables x available for feedback, it is possible to propose a control law using the gain feedback concept. In order to obtain the feedback gains k to calculate the control signal u c (t), we use the Ackermann methodology. This is possible by applying the duality theorem for controllability-observability [13] . As the pair (A, b) of system (8) The control linear theory is applied to feedback estimated states of nonlinear system that is the BM, which is described in section IV. In this work, the HM is parameterized with the mean of six patients shown in [5] [6] .
IV. Test methodology
In this work, it is proposed to test the observer and controller with a VP different from HM. Figure 1 depicts the employed configuration to test the designed controller using the estimated variables by the Luenberger observer. original BM [14] to consider the insulin delays having the next state space representation:
where G is the plasma glucose (mg/dl), X is the insulin effect over glucose elimination (1/min), I is the plasma insulin (mU/dl) S1 and S2 are the two compartments where the insulin is administered in subcutaneous route (mU). The parameters to generate the VP population with BM are taken from [4] .
B. Pump simulation description
The operation of an insulin pump is simulated as follows: 1) as the simulation iterates at 1 second and the pump infusion a bolus each 5 minutes, the control signal uc(t) is accumulated during this 5 minutes; 2) as insulin pumps cannot infusion any exact amount of insulin due to its minimum dosage ability, the insulin to be administered to the patient by the pump is adjusted to pump resolution dosage, the rounding error is added for the next infusion time; 3) if the control signal is negative (the controller indicates to extract insulin, which is impossible in real life), the insulin pump action is suspended and counts the suspension time; for each 30 minutes of suspension the pump dose a microbolus ergo minimum dosage resolution in order to avoid the catheter occlusion by insulin crystallization.
C. Implementation scenarios
To stimulate the glucose-insulin dynamic, the VP are disturbed with a diet of CHOs as follows: 40 gr at 7:30 hrs. during breakfast; 15 gr at 11:00 hrs. in a first snack; 90 gr for lunch at 13:00 hrs.; 80 gr for dinner at 19:00 horas and 15 gr for a second snack at 23:00 hrs. [15] .
Three different experiments are proposed to see the performance of the controller under different conditions.
1) Scenario 1: Target sensibility
In this experiment the reference signal is changed in order to evaluate the steady state control. The percentage of the feed-forward prandial bolus insulin K p is set to 50%. The sensitivity to reference signal is tested using four different values (80, 90, 100 and 110 mg/dl) for each VP.
2) Scenario 2: Prandial sensibility
Different proportions of prandial insulin used in CSII is administrated independently of controller. The reference is placed in 90 mg/dl. In order to test the control algorithm under distinct operation conditions, the feed-forward proportions of prandial bolus insulin K p is adjusted in 0%, 50%, 60% and 80%.
V. Results and discussion
The observer is used to estimate the unmeasurable variables of the BM. In Figure 2 A) is shown the estimation of the HM output estimated variable in order to control it applying the procedure explained in section III B) using the two different scenarios.
1) Scenario 1: Target sensibility
In Figure 4 A Figure 1. From Figure 4 A) is seen that the CL glucose, using the estimated variables, is 1.4% of the day in hyperglycemia than 4.1% of OL glucose. Both OL and CL glucose avoids hypoglycemia level this means hypoglycemia time is 0%; but, as controller is limited to sidedness, is not possible to increase the glucose level until other disturbance appears. Comparisons between OL and CL outputs in Figure 6 A) ref 100 G  mg/dl the CL mean time in hyperglycemia is 2.6% and in hypoglycemia is 0%. 6 B) ref 110
G  mg/dl, the CL mean time in hyperglycemia is 3.7% and in hypoglycemia is 0%. From the times in hypoglycemia level is possible deduce that if ref G is raised the risk of reach hypoglycemia is reduced; then raising the reference hypoglycemia risk is avoided but, in consecuense is few increased the hyperglycemia period.
2) Scenario 2: Prandial sensibility 
